Keyphrases
Gattii
100%
Cryptococcosis
81%
Cryptococcus Neoformans
71%
Molecular Type
70%
Cryptococcus Gattii
69%
Colombia
66%
Neoformans
60%
Antifungal Susceptibility
54%
Cryptococcus
54%
Core Genome multilocus Sequence Typing (cgMLST)
38%
Candida Albicans (C. albicans)
35%
Aurès
30%
Genetic Diversity
29%
Fluconazole
27%
Antimicrobial Peptides
26%
Candida Species
25%
Virulence
24%
Genotype
23%
Epidemiology
23%
Latin America (LATAM)
22%
Molecular Epidemiology
22%
Mycoses
22%
Species Complex
20%
Sequence Type
19%
C.albicans
17%
Biofilm
17%
Parapsilosis
16%
Phenotypic Diversity
16%
Veterinary
15%
Mating Type
15%
Colombians
15%
Candida Auris
15%
Antifungal Resistance
14%
North America
13%
Murine Model
13%
Cryptococcal Meningitis
13%
Virulent Strain
12%
Amphotericin B
12%
Cryptococcus Gattii Species Complex
12%
Azoles
12%
Invasive Candidiasis
11%
Peru
11%
AIDS/HIV
11%
Cryptococcus Species
11%
Antifungal Activity
11%
Fungal Infection
11%
Fluconazole Resistance
10%
Candida Parapsilosis
10%
Serotype C
10%
Immunocompromised Patients
10%
Immunology and Microbiology
Cryptococcus gattii
90%
Cryptococcus neoformans
89%
Antifungal Susceptibility
61%
Multilocus Sequence Typing
60%
Filobasidiella
47%
Genetic Variability
44%
Human immunodeficiency virus
39%
Peptides
35%
Candida
35%
Serotype
34%
Candida albicans
30%
Meningitis
28%
Molecular Epidemiology
23%
Infectious Agent
22%
Biofilm
22%
Antifungal Resistance
17%
Candida Auris
17%
Cladistics
17%
Prevalence
16%
Antifungal Activity
15%
Antimicrobial Peptides
15%
Restriction Fragment Length Polymorphism
15%
Minimum Inhibitory Concentration
13%
Immunocompromised Patient
12%
Mortality Rate
12%
Galleria mellonella
11%
Meningoencephalitis
11%
Candida parapsilosis
10%
Matrix-Assisted Laser Desorption-Ionization
9%
Time-of-Flight Mass Spectrometry
9%
Virulence Factor
9%
Microorganism
8%
Geographic Distribution
7%
Pathogenic Potential
7%
Host Range
7%
MIC50
6%
Human Pathogen
6%
Immunoproteomics
6%
Aves
6%
Immunoglobulin M
6%
Cell Viability
5%
Aspergillus
5%
Antimicrobial Agent
5%
Antimicrobial Activity
5%
Human Immunodeficiency Virus Infection
5%
Melanogenesis
5%
Wild Type
5%
Whole Genome Sequencing
5%
Central Nervous System
5%
